In order to continuously strengthen the supervision and management of the medical laboratory for the detection of novel coronavirus nucleic acid in Chengdu high tech Zone, further standardize the testing work of the tripartite testing laboratory in our district, improve the technical level and testing ability of the inspectors, and ensure the quality of laboratory testing and biological safety. According to the requirements of relevant documents such as the medical treatment team of the emergency headquarters of Sichuan Province to deal with the novel coronavirus pneumonia epidemic, entrusted by the Health Bureau of Chengdu high tech Zone, the medical quality control management service center of the high tech Zone jointly with the health supervision and law enforcement personnel of the zone launched the third round of special quality supervision on 10 third-party medical inspection laboratories for novel coronavirus nucleic acid detection in the zone on August 2, 2022.

This supervision mainly invited experts from the inspection and quality control sub center of the high tech Zone to form three expert groups to conduct on-site supervision on the tripartite medical laboratory; They are Li Hongxia, Xiong eryang, Lin Yao, Hu Ping of Chengdu first people's Hospital, Zeng Tingting of Shangjin Nanfu Hospital of West China Hospital of Sichuan University, and Huang Wei of Chengdu CDC.

The supervision expert group made a detailed inspection on the legal practice, testing qualification, quality control and various records of the nucleic acid testing laboratory through on-the-spot inspection and data access, and conducted on-site guidance, centralized feedback, and put forward rectification and Implementation Opinions on the problems found in the supervision, urging the nucleic acid testing laboratory to implement the supervision work and strengthen quality control, Effectively provide strong support for epidemic prevention and control.